Field safety experience with an autologous cancer vaccine in tumor-bearing cats: a retrospective study of 117 cases (2015–2020)

OBJECTIVES: The aim of this study was to determine the frequency and severity of adverse events (AEs) reported from use of an adjuvanted whole-cell autologous cancer vaccine in cats with solid tumors under field conditions. METHODS: The case accession database at Torigen Pharmaceuticals was searched...

Descripción completa

Detalles Bibliográficos
Autores principales: Lucroy, Michael D, Kugler, Alexa M, El-Tayyeb, Ferris, Clauson, Ryan M, Kalinauskas, Ashley E, Suckow, Mark A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160946/
https://www.ncbi.nlm.nih.gov/pubmed/34328359
http://dx.doi.org/10.1177/1098612X211031504

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160946/
https://www.ncbi.nlm.nih.gov/pubmed/34328359
http://dx.doi.org/10.1177/1098612X211031504

Ejemplares similares